Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
OCTOBER - DECEMBER 2020LIFE SCIENCES REVIEW6The Life Sciences space is fast-moving on from its traditional practices and embracing the capabilities of emerging technology to better cater to the needs of patients. Several disruptive technologies are pushing the boundaries in the pharmaceutical sector, and they will drastically change the approach at the point of care. The new technological solutions are focused on transparency and connectivity, which will ensure better patient engagement and higher levels of convenience for both the physician and the customer. The incorporation of robust data management solutions will bolster accessibility into patient information and provide better transparency into product performance. Advanced analytics, automation, and cloud are reinventing the way life science and pharmaceutical organizations function, improving the quality of decision-making and fueling the digitalization of the entire product lifecycles. All in all, digital ecosystems will play a critical role in revamping the pharmaceutical industry's performance and productivity.Therefore, to keep up with the changes in the marketplace, life science companies must incorporate the latest life science technological trends to ramp up their functionalities. Standing at the cusp of technological disruption, there is a wide variety of life science companies entering the industry with a set of advanced and integrated offerings. LSR brings to you the stories of life science technology companies to help organizations steer through the best-of-breed solutions and facilities. These organizations are transforming the pharma landscape at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject-matter experts, CIOs, and CXOs in the pharma sector on the latest industry trends, best practices, recent innovations, and highlights their expertise.Let us know your thoughts!EDITORIALThe Next Stage of Life Sciences EvolutionJeremy WilliamsManaging Editoreditor@lifesciencesreview.comCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Contact Us:Phone:510-230-0395Fax:510-894-8405Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com October - December, 2020, Vol 01, Issue - 02 Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersIssac GeorgeRonald Donovan*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffManaging EditorJeremy WilliamsSalesStephen Thomas
< Page 5 | Page 7 >